Filing Details

Accession Number:
0000921895-19-002384
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-09 18:14:16
Reporting Period:
2019-09-05
Accepted Time:
2019-09-09 18:14:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
835887 Progenics Pharmaceuticals Inc PGNX Pharmaceutical Preparations (2834) 133379479
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1672828 Lte Partners, Llc C/O Lte Management, Llc
450 West 31St Street, 12Th Fl
New York NY 10001
No No Yes Yes
1785671 Lte Management, Llc 450 West 31St Street
12Th Fl
New York NY 10001
No No Yes Yes
1785674 Melkonian Capital Management, Llc 450 West 31St Street
12Th Fl
New York NY 10001
No No Yes Yes
1785720 Ryan Melkonian C/O Melkonian Capital Management, Llc
450 West 31St Street, 12Th Fl
New York NY 10001
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0013 Par Value Acquisiton 2019-09-05 43,520 $4.62 1,928,520 No 4 P Direct
Common Stock, $0.0013 Par Value Acquisiton 2019-09-09 21,480 $4.94 1,950,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This Form 4 is filed jointly by LTE Partners, LLC ("LTE"), Melkonian Capital Management, LLC ("MCM"), LTE Management, LLC ("LTE Management"), and Ryan Melkonian (collectively, the "Reporting Persons"). The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons disclaim beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, the Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
  2. Securities owned directly by LTE. Each of MCM, as the sole investment advisor to LTE, and LTE Management, as the sole manager of LTE, may be deemed tobeneficially own the securities owned directly by LTE. Mr. Melkonian, in his capacities as (i) the sole manager and majority member of LTE Management and (ii) the Chief Investment Officer, Management Member and majority owner of MCM, may also be deemed to beneficially own the securities owned directly by LTE.